{"rows":[{"id":2459,"title":"Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.","authors":"Andersson M, Persson M, Kjellgren A","journal":"Harm reduction journal","publication_date":"2017-09-05","publication_year":2017,"doi":"10.1186/s12954-017-0186-6","pubmed_id":"28870224","openalex_id":"https://openalex.org/W2751240458","source_url":"https://pubmed.ncbi.nlm.nih.gov/28870224/","substance_tags":"psilocybin","topic_tags":"Headache / Migraine,Safety,Adverse Events","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:26","bibtex":null,"source_record_id":"PMID:28870224","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/28870224/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:28870224","source_url":"https://pubmed.ncbi.nlm.nih.gov/28870224/","doi":"10.1186/s12954-017-0186-6","pmid":"28870224","publication_date":"2017-09-05","importer_version":"2.1.3","text_redistributed":false}},{"id":2337,"title":"Psychedelic microdosing benefits and challenges: an empirical codebook.","authors":"Anderson T, Petranker R, Christopher A, Rosenbaum D, Weissman C, Dinh-Williams LA, Hui K, Hapke E","journal":"Harm reduction journal","publication_date":"2019-07-10","publication_year":2019,"doi":"10.1186/s12954-019-0308-4","pubmed_id":"31288862","openalex_id":"https://openalex.org/W2957955970","source_url":"https://pubmed.ncbi.nlm.nih.gov/31288862/","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Mechanism of Action,Aging,Microdosing,Healthcare Workers,Adverse Events","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:25","bibtex":null,"source_record_id":"PMID:31288862","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31288862/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31288862","source_url":"https://pubmed.ncbi.nlm.nih.gov/31288862/","doi":"10.1186/s12954-019-0308-4","pmid":"31288862","publication_date":"2019-07-10","importer_version":"2.1.3","text_redistributed":false}},{"id":2318,"title":"Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube.","authors":"Andersson M, Kjellgren A","journal":"Harm reduction journal","publication_date":"2019-11-28","publication_year":2019,"doi":"10.1186/s12954-019-0333-3","pubmed_id":"31779667","openalex_id":"https://openalex.org/W2991503240","source_url":"https://pubmed.ncbi.nlm.nih.gov/31779667/","substance_tags":"psilocybin","topic_tags":"Depression,Microdosing,Emotional Processing,Safety,Drug Interactions","study_type":"Qualitative Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:24","bibtex":null,"source_record_id":"PMID:31779667","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/31779667/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:31779667","source_url":"https://pubmed.ncbi.nlm.nih.gov/31779667/","doi":"10.1186/s12954-019-0333-3","pmid":"31779667","publication_date":"2019-11-28","importer_version":"2.1.3","text_redistributed":false}},{"id":1411,"title":"Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel.","authors":"Bonny-Noach H, Shapira B, Baumol P, Tadmor N, Rosca P, Shoshan S, Harel-Fisch Y, Caduri A","journal":"Harm reduction journal","publication_date":"2023-08-09","publication_year":2023,"doi":"10.1186/s12954-023-00845-3","pubmed_id":"37559046","openalex_id":"https://openalex.org/W4385698697","source_url":"https://pubmed.ncbi.nlm.nih.gov/37559046/","substance_tags":"psilocybin","topic_tags":"Addiction,Observational Study,Toxicity","study_type":"Observational Study","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:13","bibtex":null,"source_record_id":"PMID:37559046","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/37559046/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:37559046","source_url":"https://pubmed.ncbi.nlm.nih.gov/37559046/","doi":"10.1186/s12954-023-00845-3","pmid":"37559046","publication_date":"2023-08-09","importer_version":"2.1.3","text_redistributed":false}},{"id":480,"title":"Harm reduction practises for users of psychedelic drugs: a scoping review.","authors":"Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P","journal":"Harm reduction journal","publication_date":"2025-10-03","publication_year":2025,"doi":"10.1186/s12954-025-01264-2","pubmed_id":"41044617","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/41044617/","substance_tags":"psilocybin","topic_tags":"Review Article,Safety","study_type":"Review Article","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:56","bibtex":null,"source_record_id":"PMID:41044617","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41044617/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41044617","source_url":"https://pubmed.ncbi.nlm.nih.gov/41044617/","doi":"10.1186/s12954-025-01264-2","pmid":"41044617","publication_date":"2025-10-03","importer_version":"2.1.3","text_redistributed":false}},{"id":423,"title":"Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community.","authors":"Kruger DJ, Mersereau G, Sullivan A, Barron J, Herberholz M, Pouyan N, Aday JS, Boehnke KF","journal":"Harm reduction journal","publication_date":"2025-11-25","publication_year":2025,"doi":"10.1186/s12954-025-01337-2","pubmed_id":"41291774","openalex_id":"https://openalex.org/W4416671509","source_url":"https://pubmed.ncbi.nlm.nih.gov/41291774/","substance_tags":"psilocybin","topic_tags":"Clinical Trial,Observational Study,Safety","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:55","bibtex":null,"source_record_id":"PMID:41291774","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41291774/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41291774","source_url":"https://pubmed.ncbi.nlm.nih.gov/41291774/","doi":"10.1186/s12954-025-01337-2","pmid":"41291774","publication_date":"2025-11-25","importer_version":"2.1.3","text_redistributed":false}}],"total":6,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Harm reduction journal","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}